Brief: RhoVac Granted EUR 2.5 Mln From Horizon 2020

Chosa Oncology AB

22/08/2019 08:34

Aug 22 (Reuters) - RhoVac AB  RHOVAC.TE :
    * HAS BEEN GRANTED 2.5 MILLION EURO FROM HORIZON 2020
    * GRANT FROM EU FRAMEWORK PROGRAM HORIZON 2020 RUNS OVER 36
MONTHS
    * GRANT SUPPORTS CO'S FURTHER DEVELOPMENT OF RV001 PROJECT
FOR
PROSTATE CANCER TREATMENT, AS WELL AS CONTINUED BUSINESS
DEVELOPMENT WITH AIM OF REACHING AGREEMENT WITH FUTURE PARTNER

Source text for Eikon:  ID:nWkr5gpXfh 
Further company coverage:  RHOVAC.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))